title: [Hyperthyroidism caused by a TSH producing pituitary adenoma].
abstract: Elevated levels of free triiodothyronine (fT3) of 8.8 ng/dl (normal range 2.0 to 4.2) and free thyroxin (fT4) of 3.5 pg/ml (0.8 to 1.7) were found in the course of an examination of a 53-year old patient due to a planned hysterectomy. As thyrotropin (TSH) also was elevated with 5.8 mU/l (0.4 to 4.5), these findings corresponded to an inappropriate secretion of TSH (IST). Additional examinations revealed a blunted rise of TSH secretion after i.v. injection of 200 micrograms thyrotropin releasing hormone (TRH) as well as lacking suppression of TSH secretion after oral doses of 75 micrograms T3 during one week. alpha-TSH levels with 3.7 micrograms/l were elevated in comparison to a matched normal sample just as the molar ratio alpha-TSH/TSH with 6.95 and sex hormone-binding globulin (SHBG) with 175 nmol/l and showed an absence of inhibition in the T3 suppression test. These results were suggestive of neoplastic inappropriate secretion of TSH (nIST) due to a TSH-secreting pituitary adenoma. In concordance, the magnetic resonance imaging (MRI) showed a 1 cm tumor in the sella. The adenoma could also be visualized by 111In-octreotide and 123I-epidepride scintigraphies of the pituitary gland. After transsphenoidal resection, histological examination of the tumor resulted in the finding of a TSH-secreting adenoma. Postoperative TSH levels were not detectable, indicating the complete removal of the adenoma. Levels of fT3 and fT4 were slightly below normal with 1.9 pg/ml and 0.7 ng/dl, respectively. A control scintigraphy with 111In-octreotide following an equivocal MRI showed no uptake in the pituitary.
authors.affiliation: Institut für Nuklearmedizin, Krankenhaus Lainz.
authors.forename: F
authors.initials: F
authors.lastname: Prasch
authors.forename: S E
authors.initials: SE
authors.lastname: Knosp
authors.forename: R
authors.initials: R
authors.lastname: Steinbach
authors.forename: S
authors.initials: S
authors.lastname: Wogritsch
authors.forename: I
authors.initials: I
authors.lastname: Hurtl
authors.forename: M
authors.initials: M
authors.lastname: Greifeneder
authors.forename: C
authors.initials: C
authors.lastname: Holm
authors.forename: C
authors.initials: C
authors.lastname: Najemnik
authors.forename: R
authors.initials: R
authors.lastname: Dudczak
mesh_terms: D000236:Adenoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000601:surgery; D001549:Benzamides; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology*; D007044:Hysterectomy; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D015282:Octreotide / Q000031:analogs & derivatives; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000378:metabolism / Q000601:surgery; D011759:Pyrrolidines; D011877:Radionuclide Imaging; D012016:Reference Values; D013972:Thyrotropin / Q000096:biosynthesis / Q000097:blood* / Q000378:metabolism*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D001549:Benzamides; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; C094279:indium-111-octreotide; D014284:Triiodothyronine; C063525:epidepride; D013972:Thyrotropin; D013974:Thyroxine; D015282:Octreotide